advertisement
Grauslund J 8
Showing records 1 to 8 | Display all abstracts from Grauslund J105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Dysager DD
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Sperling S
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Koren SF
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Stokholm L; Thykjaer AS
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Grauslund J; Wied J
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Pedersen FN
Acta Ophthalmologica 2023; 101: 384-391
105961 Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Floaters: A Systematic Review with Meta-Analyses
Subhi Y
Ophthalmology and therapy 2022; 11: 2225-2242
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Möller S; Laugesen CS; Andersen N; Andresen J; Bek T; la Cour M; Hajari J; Heegaard S; Højlund K; Kawasaki R; Kolko M; Schielke KC; Rubin KH; Vestergaard AH; Grauslund J
Acta Ophthalmologica 2023; 101: 384-391
